Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
SOPHiA GENETICS is a healthcare technology company dedicated to advancing Data-Driven Medicine. Their cloud-based SOPHiA DDM™ platform leverages AI and machine learning to analyze complex genomic and multimodal data, providing actionable insights to healthcare professionals. This enables faster and more accurate diagnosis, prognosis, and treatment decisions for patients with cancer and rare diseases. By democratizing access to advanced analytics, SOPHiA GENETICS aims to improve health outcomes globally and accelerate the development of new therapies.
Serves as the central hub for global operations, research and development, corporate strategy, and administrative functions. Key decisions regarding product development and global expansion are driven from here.
Located near the Lake Geneva region, an area known for its concentration of biotech and medtech companies. The facilities are modern, designed to foster collaboration and innovation, likely incorporating advanced labs and data centers.
The HQ fosters an innovative, collaborative, and mission-driven work culture. Employees are typically passionate about leveraging technology to improve healthcare, working in a fast-paced, intellectually stimulating environment.
The Swiss headquarters is significant due to its establishment in a country known for its strong pharmaceutical and biotech sectors, providing access to talent, research institutions (like nearby EPFL), and a supportive ecosystem for life sciences innovation.
SOPHiA GENETICS supports healthcare institutions, laboratories, and biopharmaceutical companies across more than 70 countries. Its decentralized SOPHiA DDM™ platform allows global users to analyze genomic and multimodal data locally while benefiting from collective intelligence, fostering a worldwide network for data-driven medicine.
Rue du Centre 172
Saint-Sulpice
Vaud
Switzerland
Address: 60 State Street, Suite 700, Boston, MA 02109, USA
To expand market presence in North America, engage with key opinion leaders, and support a growing customer base of hospitals and labs in the region.
Address: Technopole Izarbel, Allée Théodore Monod, 64210 Bidart, France
To leverage local tech talent and contribute to the core technological advancements of the company's offerings.
Address: Level 39, Marina Bay Financial Centre Tower 2, 10 Marina Boulevard, Singapore 018983
To expand the company's footprint in the APAC region, adapting solutions to local healthcare needs and fostering partnerships.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, SOPHiA GENETICS' leadership includes:
SOPHiA GENETICS has been backed by several prominent investors over the years, including:
SOPHiA GENETICS has seen significant leadership changes in the past year, including a new CFO, a new CCO, and an interim CEO appointment, signaling strategic shifts and focus on commercial growth and operational efficiency.
Discover the tools SOPHiA GENETICS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SOPHiA GENETICS commonly uses the [first_initial][last_name]@sophiagenetics.com and [first_name].[last_name]@sophiagenetics.com email formats. Understanding these patterns can be helpful for professional communication.
[first_initial][last_name]@sophiagenetics.com or [first_name].[last_name]@sophiagenetics.com
Format
jdoe@sophiagenetics.com or jane.doe@sophiagenetics.com
Example
90%
Success rate
SOPHiA GENETICS Investor Relations • March 5, 2024
SOPHiA GENETICS announced its financial results for Q4 and full-year 2023, highlighting revenue growth and platform adoption. The company emphasized ongoing investments in R&D and commercial expansion....more
SOPHiA GENETICS Investor Relations • January 9, 2024
The company announced that Co-Founder Dr. Jurgi Camblong would step down as CEO, with Dr. Philippe Menu appointed Interim CEO. Peter Casasanto was also appointed as Chief Commercial Officer to drive commercial strategy....more
SOPHiA GENETICS Investor Relations • October 3, 2023
SOPHiA GENETICS announced the appointment of Ross Muken as its new Chief Financial Officer, effective October 16, 2023, succeeding Hadas Manor....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including SOPHiA GENETICS, are just a search away.